PriceTargets.com logo

Invacare - IVC Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $2.00
  • Forecasted Upside: ∞
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 02/1/2023 09:00 AM ET
+0 (0.00%)
Get New Invacare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IVC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IVC

Analyst Price Target is $2.00
▲ +∞ Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Invacare in the last 3 months. The average price target is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for IVC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Invacare. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/15/2022OppenheimerLower Target$2.00Low
10/29/2021OppenheimerLower TargetOutperform$11.00 ➝ $9.00High
9/10/2021Needham & Company LLCLower TargetBuy$17.00 ➝ $8.00Medium
8/19/2021OppenheimerInitiated CoverageOutperform$11.00High
7/14/2020Needham & Company LLCReiterated RatingBuyHigh
6/1/2020Needham & Company LLCReiterated RatingBuy$17.00Medium
5/7/2020Needham & Company LLCReiterated RatingBuy$17.00High
4/14/2020Needham & Company LLCReiterated RatingBuy$17.00High
3/23/2020StephensLower TargetOverweight$17.00 ➝ $11.00High
3/9/2020Needham & Company LLCReiterated RatingBuy$17.00Low
2/10/2020Needham & Company LLCReiterated RatingBuy$17.00Medium
11/6/2019Needham & Company LLCReiterated RatingBuy$15.00High
10/10/2019Needham & Company LLCReiterated RatingBuy$15.00Low
4/9/2019Needham & Company LLCReiterated RatingBuy$15.00Low
2/14/2019Needham & Company LLCReiterated RatingBuy$15.00High
1/24/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$15.00High
(Data available from 9/27/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/1/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/31/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/30/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Invacare logo
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.50
Low: $0.35
High: $0.74

52 Week Range

Now: N/A

Volume

33,301 shs

Average Volume

240,305 shs

Market Capitalization

$20.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Invacare?

The following sell-side analysts have issued stock ratings on Invacare in the last twelve months: Oppenheimer Holdings Inc., and StockNews.com.
View the latest analyst ratings for IVC.

What is the current price target for Invacare?

1 Wall Street analysts have set twelve-month price targets for Invacare in the last year. Their average twelve-month price target is $2.00. Oppenheimer Holdings Inc. has the highest price target set, predicting IVC will reach $2.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $2.00 for Invacare in the next year.
View the latest price targets for IVC.

What is the current consensus analyst rating for Invacare?

Invacare currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for IVC.

What other companies compete with Invacare?

Other companies that are similar to Invacare include Nutriband, Predictive Oncology, Sientra, OceanTech Acquisitions I and ReWalk Robotics. Learn More about companies similar to Invacare.

How do I contact Invacare's investor relations team?

Invacare's physical mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider's listed phone number is (440) 329-6000 and its investor relations email address is [email protected]. The official website for Invacare is www.invacare.com. Learn More about contacing Invacare investor relations.